Expression of Streptomyces peucetius genes for doxorubicin resistance and aklavinone 11-hydroxylase in Streptomyces galilaeus ATCC 31133 and production of a hybrid aclacinomycin.
The aklavinone 11-hydroxylase gene and two doxorubicin resistance genes cloned from Streptomyces peucetius subsp. caesius ATCC 27952 were introduced into doxorubicin-sensitive Streptomyces galilaeus ATCC 31133, an aclacinomycin producer. The doxorubicin resistance genes drrA and drrB endowed S. galilaeus with high-level resistance to doxorubicin, indicating that the resistance mechanism for doxorubicin might be different from that for aclacinomycin A. Transformation of S. galilaeus ATCC 31133 with plasmid pMC213 containing the aklavinone 11-hydroxylase gene (dnrF) resulted in the production of many red pigments. A new metabolite was purified, and the position of the newly introduced hydroxyl group was determined. This result indicated that the aklavinone 11-hydroxylase gene was stably expressed in S. galilaeus ATCC 31133 and that it gave rise to a hybrid aclacinomycin A which showed highly specific in vitro cytotoxicity against leukemia and melanoma cell lines.
D015250:Aclarubicin / Q000031:analogs & derivatives* / Q000096:biosynthesis; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D002240:Carbohydrate Sequence; D004317:Doxorubicin / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D015870:Gene Expression; D005798:Genes, Bacterial; D006801:Humans; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000188:drug therapy; D013302:Streptomyces / Q000201:enzymology / Q000235:genetics* / Q000378:metabolism*; D014407:Tumor Cells, Cultured / Q000187:drug effects
C096891:11-hydroxyaclacinomycin A; C011157:aclacinomycins; D015250:Aclarubicin; D004317:Doxorubicin; C090407:aklavinone 11-hydroxylase; D001189:Aryl Hydrocarbon Hydroxylases